ANTI-HYPERTENSIVES

Reference standards play a crucial role in ensuring the quality, safety, and efficacy of anti-hypertensive medications. These standards, established by regulatory authorities such as the United States Pharmacopeia (USP) or the European Pharmacopoeia (EP), provide a benchmark against which the identity, purity, strength, and other quality attributes of anti-hypertensive drugs can be measured. By using reference standards, manufacturers can confirm that their products meet the required specifications and are consistent with the approved methods of analysis. This helps to ensure that patients receive medications that are safe, effective, and of high quality, ultimately contributing to the successful management of hypertension and reducing the risk of associated complications.